Evidence map›Paper›PMID 30298378›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?

Frederik A Verburg, Luca Giovanella, Ioannis Iakovou, Mark W Konijnenberg, Werner Langsteger, Michael Lassmann, Jasna Mihailovic, Markus Luster

Open access · bronzeAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Estimating the Risk for Secondary Cancer After Targeted α-Therapy withJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  2. Article
  3. Article
  4. Review
  5. Guidelines Are Not Gospel!Thyroid : official journal of the American Thyroid Association · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 6 countries.

Frederik A VerburgDepartment of Nuclear Medicine, University Hospital Marburg, Baldinger Straße, 35043, Marburg, Germany. verburg@med.uni-marburg.de.ORCID http://orcid.org/0000-0002-7161-0979
Luca GiovanellaDepartment of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Ioannis IakovouAcademic Department of Nuclear Medicine, Papageorgiou Hospital, Thessaloniki, Greece.
Mark W KonijnenbergDepartment of Nuclear Medicine, Erasus MC, Rotterdam, The Netherlands.
Werner LangstegerDepartment of Nuclear Medicine and Endocrinology, PET-CT Center LINZ, St Vincent's Hospital, Linz, Austria.
Michael LassmannDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Jasna MihailovicDepartment of Nuclear Medicine, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia.
Markus LusterDepartment of Nuclear Medicine, University Hospital Marburg, Baldinger Straße, 35043, Marburg, Germany.
Philipps University of Marburg · DEInstitute of Oncology Research · CHOncology Institute of Vojvodina · RSPapageorgiou General Hospital · GRSaint Vincent's Catholic Medical Center · USUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Iodine RadioisotopesThyroid NeoplasmsHematologic NeoplasmsHumansIncidenceIodine-131Iodine Radioisotopes

Identifiers

PMID30298378
OpenAlexW2895965318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.